Literature DB >> 8672823

Self-initiated modification of hypertension treatment in response to perceived problems.

S H Wallenius1, K K Vainio, M J Korhonen, A G Hartzema, H K Enlund.   

Abstract

OBJECTIVE: To assess the prevalence of patient-initiated modification of drug instructions and the association between different classes of problems and the modification of hypertension therapy. DESIGN AND METHODS: In this cross-sectional study, all patients (n = 1215) who had been examined at a hypertension clinic during a 1-year period were surveyed. The response rate to the questionnaire was 85%. Of the 1035 respondents, 623 currently taking antihypertensive medication (self-report) were included in the study.
RESULTS: Of the patients taking antihypertensive drugs, 36% admitted that they had tried to manage their condition with a lower dosage and/or fewer drugs than prescribed. The percentage of patients who modified their drug regimen decreased with increasing age. One or more problems with the treatment of hypertension were reported by 79% of the respondents. The odds ratio (95% confidence interval) for modification among patients who reported 1 or more problems compared with those not reporting any problem was 3.5 (2.12 to 5.67). The prevalence of modification increased with the number of problems; this was seen in all age groups and among men and women.
CONCLUSIONS: Perceived problems in drug taking in the treatment of hypertension have an important impact on the prevalence of modifying drug instructions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8672823     DOI: 10.1177/106002809502901204

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  7 in total

1.  Patients' views about taking antihypertensive drugs: questionnaire study.

Authors:  John Benson; Nicky Britten
Journal:  BMJ       Date:  2003-06-14

2.  Perceived medication use challenges and coping strategies among medical outpatients in Nigeria.

Authors:  Kazeem B Yusuff
Journal:  Int J Clin Pharm       Date:  2012-10-11

3.  The effects of antitussive treatment of ACE inhibitor-induced cough on therapy compliance: a prescription sequence symmetry analysis.

Authors:  Stefan Vegter; Pieter de Boer; Klaas Willem van Dijk; Sipke Visser; Lolkje T W de Jong-van den Berg
Journal:  Drug Saf       Date:  2013-06       Impact factor: 5.606

4.  Persistence with antihypertensive treatments: results of a 3-year follow-up cohort study.

Authors:  Joerg Hasford; Detlef Schröder-Bernhardi; Marietta Rottenkolber; Karel Kostev; Gerhard Dietlein
Journal:  Eur J Clin Pharmacol       Date:  2007-08-14       Impact factor: 2.953

Review 5.  Therapeutic Inertia and Treatment Intensification.

Authors:  Robina Josiah Willock; Joseph B Miller; Michelle Mohyi; Ahmed Abuzaanona; Meri Muminovic; Phillip D Levy
Journal:  Curr Hypertens Rep       Date:  2018-01-29       Impact factor: 5.369

6.  The efficacy and safety of valsartan in obese and non-obese pediatric hypertensive patients.

Authors:  Kevin E C Meyers; Kenneth Lieberman; Susan Solar-Yohay; Guangyang Han; Victor Shi
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-07-14       Impact factor: 3.738

7.  Patients' blood pressure knowledge, perceptions and monitoring practices in community pharmacies.

Authors:  Jennifer Y Lam; Lisa M Guirguis
Journal:  Pharm Pract (Granada)       Date:  2010-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.